Tevogen Inc. (TVGNW) stock
TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN
$0.09+0.01 (+18.24%)
Close on Oct 30, 2026Market cap $38.42MP/E –Yield –
Tevogen cash
Cash and short-term investments held at the end of each period.
Tevogen's cash was $1.08M at Jun 30, 2026. For fiscal 2025 it was $552.37K, down 56.9% from the year before. The highest annual figure on record is $5.48M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $552.37K | -56.9% |
| FY2024 | Dec 31, 2024 | $1.28M | +21.9% |
| FY2023 | Dec 31, 2023 | $1.05M | -80.8% |
| FY2022 | Dec 31, 2022 | $5.48M | +1491.6% |
| FY2021 | Dec 31, 2021 | $344.58K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.08M | +57.9% |
| Q1 FY2026 | Mar 31, 2026 | $692.31K | -64.9% |
| Q4 FY2025 | Dec 31, 2025 | $552.37K | -56.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.04M | -55.5% |
| Q2 FY2025 | Jun 30, 2025 | $685.23K | -39.6% |
| Q1 FY2025 | Mar 31, 2025 | $1.97M | +49.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.28M | +21.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.33M | -10.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.14M | -67.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.32M | -76.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.05M | -80.8% |
| Q3 FY2023 | Sep 30, 2023 | $2.61M | +1722.2% |
| Q2 FY2023 | Jun 30, 2023 | $3.46M | +1761.9% |
| Q1 FY2023 | Mar 31, 2023 | $5.67M | +2350.5% |
| Q4 FY2022 | Dec 31, 2022 | $5.48M | +1491.6% |
| Q3 FY2022 | Sep 30, 2022 | $143.05K | – |
| Q2 FY2022 | Jun 30, 2022 | $185.65K | – |
| Q1 FY2022 | Mar 31, 2022 | $231.55K | – |
| Q4 FY2021 | Dec 31, 2021 | $344.58K | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |